Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFA/iLRP Dendritic Cell Vaccine in Metastatic Breast Cancer
NCT00879489Phase 2Unknown
- Sponsor
- Quantum Immunologics
- Start
- May 2008
- Primary completion
- Mar 2011
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of oncofetal antigen/immature laminin receptor protein-pulsed autologous dendritic cells in breast cancer, sponsored by Quantum Immunologics. Status: unknown.
02
Drugs
oncofetal antigen/immature laminin receptor protein-pulsed autologous dendritic cells
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00879489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879489.